News

AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial
AAVB-039 delivers the full-length ABCA4 -protein, addressing the root cause of the disease and enabling treatment of all patients, independent of mutationCELESTE is informed by the STELLA prospective ...
Comic Book Movie17h
Will The DCU's Batman Debut In CLAYFACE? We Have Details On That And The Movie's Lead And Supporting Cast
New character details for DC Studios’ Clayface have been revealed, including the movie’s lead, love interest, love rival, and ...